Cargando…
The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840225/ https://www.ncbi.nlm.nih.gov/pubmed/36649824 http://dx.doi.org/10.1016/j.jinf.2023.01.014 |
| _version_ | 1784869597354131456 |
|---|---|
| author | Liu, Ting-Hui Wu, Jheng-Yan Huang, Po-Yu Tsai, Ya-Wen Lai, Chih-Cheng |
| author_facet | Liu, Ting-Hui Wu, Jheng-Yan Huang, Po-Yu Tsai, Ya-Wen Lai, Chih-Cheng |
| author_sort | Liu, Ting-Hui |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9840225 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98402252023-01-17 The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients Liu, Ting-Hui Wu, Jheng-Yan Huang, Po-Yu Tsai, Ya-Wen Lai, Chih-Cheng J Infect Letter to the Editors The British Infection Association. Published by Elsevier Ltd. 2023-03 2023-01-14 /pmc/articles/PMC9840225/ /pubmed/36649824 http://dx.doi.org/10.1016/j.jinf.2023.01.014 Text en © 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editors Liu, Ting-Hui Wu, Jheng-Yan Huang, Po-Yu Tsai, Ya-Wen Lai, Chih-Cheng The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients |
| title | The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients |
| title_full | The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients |
| title_fullStr | The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients |
| title_full_unstemmed | The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients |
| title_short | The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients |
| title_sort | effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following covid-19: a retrospective cohort study including 91,528 patients |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840225/ https://www.ncbi.nlm.nih.gov/pubmed/36649824 http://dx.doi.org/10.1016/j.jinf.2023.01.014 |
| work_keys_str_mv | AT liutinghui theeffectofnirmatrelvirplusritonavironthelongtermriskofepilepsyandseizurefollowingcovid19aretrospectivecohortstudyincluding91528patients AT wujhengyan theeffectofnirmatrelvirplusritonavironthelongtermriskofepilepsyandseizurefollowingcovid19aretrospectivecohortstudyincluding91528patients AT huangpoyu theeffectofnirmatrelvirplusritonavironthelongtermriskofepilepsyandseizurefollowingcovid19aretrospectivecohortstudyincluding91528patients AT tsaiyawen theeffectofnirmatrelvirplusritonavironthelongtermriskofepilepsyandseizurefollowingcovid19aretrospectivecohortstudyincluding91528patients AT laichihcheng theeffectofnirmatrelvirplusritonavironthelongtermriskofepilepsyandseizurefollowingcovid19aretrospectivecohortstudyincluding91528patients AT liutinghui effectofnirmatrelvirplusritonavironthelongtermriskofepilepsyandseizurefollowingcovid19aretrospectivecohortstudyincluding91528patients AT wujhengyan effectofnirmatrelvirplusritonavironthelongtermriskofepilepsyandseizurefollowingcovid19aretrospectivecohortstudyincluding91528patients AT huangpoyu effectofnirmatrelvirplusritonavironthelongtermriskofepilepsyandseizurefollowingcovid19aretrospectivecohortstudyincluding91528patients AT tsaiyawen effectofnirmatrelvirplusritonavironthelongtermriskofepilepsyandseizurefollowingcovid19aretrospectivecohortstudyincluding91528patients AT laichihcheng effectofnirmatrelvirplusritonavironthelongtermriskofepilepsyandseizurefollowingcovid19aretrospectivecohortstudyincluding91528patients |